Acurx Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO David Luci, with a market cap of $8.3M.
Based on Q1 2026 filing
Common questions about Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. (ACXP) has a market capitalization of $8.3M and trades on NASDAQ.
Acurx Pharmaceuticals, Inc. has approximately 4 employees.